About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Alembic Pharmaceuticals Ltd.
BSE Code
533573
ISIN Demat
INE901L01018
Book Value
269.55
NSE Code
APLLTD
Dividend Yield %
1.23
Market Cap
175521.04
P/E
40.78
EPS
21.90
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
29-Oct-2025
898.25
913.10
898.25
901.05
4125
3727579
28-Oct-2025
915.00
919.50
904.50
905.35
2219
2013409
27-Oct-2025
926.05
926.05
911.60
915.75
5301
4874758
24-Oct-2025
912.00
932.70
910.00
923.70
3126
2878196
23-Oct-2025
921.55
937.40
917.20
922.20
1805
1670147
21-Oct-2025
933.35
933.80
931.80
932.05
259
241479
20-Oct-2025
984.95
984.95
928.85
930.30
1175
1101370
17-Oct-2025
935.90
950.20
931.60
937.50
1787
1679379
16-Oct-2025
912.75
939.00
912.75
935.25
1554
1445243
15-Oct-2025
915.55
926.00
915.55
917.50
3873
3569056
14-Oct-2025
955.25
955.25
911.25
916.95
2000
1865336
13-Oct-2025
940.85
948.10
939.30
943.60
1100
1035887
10-Oct-2025
928.35
950.00
928.25
947.85
4633
4365587
09-Oct-2025
930.80
934.90
921.80
929.95
3607
3349580
08-Oct-2025
917.50
940.00
916.00
934.85
3779
3494221
07-Oct-2025
912.50
922.00
909.00
917.80
4837
4426541
06-Oct-2025
936.95
936.95
905.00
907.25
2643
2413012
03-Oct-2025
911.20
921.00
905.90
911.00
3455
3155181
01-Oct-2025
904.00
911.05
896.60
904.20
1966
1775262
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.